Injective Protocol has activated its IIP-677 mainnet upgrade, introducing Injective Mint, a platform for issuing SEC- and MiCA-compliant tokenized equities and bonds. The upgrade improves cross-chain interoperability, reduces block times, and optimizes staking for its native INJ token. This move positions Injective as a leader in compliant real-world asset tokenization, with over $6.8B in cumulative RWA trading volume and $1.1B in tokenized assets on the platform. Compliance with US and European regulations is a key competitive advantage, supported by strong governance approval.
Canary Capital submitted a preliminary filing on Sept. 24 for an Injective (INJ) ETF that plans to stake at least 90% of its INJ tokens to earn rewards. The fund's daily net asset value will reflect staking rewards, but no cash rewards will be paid t...
Among the 90 largest cryptocurrencies, MemeCore (M) surged 17.03% in 24 hours, leading gains while 72 out of 90 assets declined. Other notable risers included Lighter (8.54%), Monero (5.85%), and Bitway (5.53%). Conversely, LayerZero fell the most by...
Injective (INJ) traded below the key $8.90 level on October 22, falling 7% within 24 hours. This dip puts into question a previous bullish technical scenario that required daily closes above $8.90 to remain valid. While the intraday price dropped bel...
Canary Capital proposes an Injective (INJ) ETF that reinvests staking rewards back into the fund rather than distributing cash to shareholders. The fund delegates tokens to validators on the Injective network, with staking rewards paid in INJ tokens....
The price of Injective's native token, INJ, fell 7% to $8.15 in a 24-hour period ending October 22. This decline was captured in a specific market snapshot and does not indicate the cause of the drop. Injective operates a monthly Community BuyBack pr...
